Showing results (261-270 of 317) with videos related to

Sort By:
Pageof 32
Haematologica|January 8, 2026
Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in TP53-mutated myelodysplastic syndromesMahmood Aldapt, Yu-Hung Wang, Kashish J Shah, et al.
Haematologica|February 1, 2024
Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasmsAnmol Baranwal, Mark Gurney, Rami Basmaci, et al.
Cell Death and Differentiation|March 28, 2024
AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell deathJia Jia, Wenbo Ji, Antoine N Saliba, et al.
Mayo Clinic Proceedings|July 7, 2018
Clinical Correlates and Treatment Outcomes for Patients With Short Telomere SyndromesAbhishek A Mangaonkar, Alejandro Ferrer, Filippo Pinto E Vairo, et al.
Blood Cancer Journal|April 11, 2023
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasmsMithun Vinod Shah, Elizabeth Ngoc Hoa Tran, Syed Shah, et al.
American Journal of Hematology|August 14, 2021
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromesEmma St Martin, Alejandro Ferrer, Abhishek A Mangaonkar, et al.
Blood Cancer Journal|November 6, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh, et al.
Acta Haematologica|June 8, 2026
Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignanciesMaymona Abdelgamid, Naima J Hashi, Mehrdad Hefazi, et al.
American Journal of Hematology|March 13, 2025
Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative CasesSaubia Fathima, Maymona Abdelmagid, Ali Alsugair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2023
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMMLChristopher T Letson, Maria E Balasis, Hannah Newman, et al.
Pageof 32